Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Anwar, Sumadi Lukman ^a   Krech, Till ^a   Hasemeier, Britta ^a   Schipper, Elisa ^a   Schweitzer, Nora ^a   Vogel, Arndt ^a   Kreipe, Hans ^a   Lehmann, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; DNA METHYLTRANSFERASE 1 GENE; EPIGENETICS; GENE IDENTIFICATION; GENE LOCUS; GENE LOSS; GENE SWITCHING; GENETIC SCREENING; GENOME IMPRINTING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; MEG3 GENE; ONCOGENE;

ALLELES; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MEMBRANE PROTEINS; RNA, LONG UNTRANSLATED;

EID: 84869052714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049462     Document Type: Article

References (48)

1. Knudson AG, (2002) Cancer genetics. Am J Med Genet 111: 96-102.
2. Iacobuzio-Donahue CA, (2008) Epigenetic Changes in Cancer. Annu Rev Pathol.
3. Morison IM, Ramsay JP, Spencer HG, (2005) A census of mammalian imprinting. Trends in genetics: TIG 21: 457-465.
4. Varmuza S, Mann M, (1994) Genomic imprinting-defusing the ovarian time bomb. Trends Genet 10: 118-123.
5. Youngson NA, Whitelaw E, (2008) Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 9: 233-257.
6. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE, (1996) Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med 2: 311-316.
7. Weksberg R, Shuman C, Beckwith JB, (2010) Beckwith-Wiedemann syndrome. Eur J Hum Genet 18: 8-14.
8. Engel JR, Smallwood A, Harper A, Higgins MJ, Oshimura M, et al. (2000) Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. Journal of medical genetics 37: 921-926.
9. Schulz R, McCole RB, Woodfine K, Wood AJ, Chahal M, et al. (2009) Transcript- and tissue-specific imprinting of a tumour suppressor gene. Hum Mol Genet 18: 118-127.
10. DeVeale B, van der Kooy D, Babak T, (2012) Critical evaluation of imprinted gene expression by RNA-Seq: a new perspective. PLoS Genet 8: e1002600.
11. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B, (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155-158.
12. Schroeder WT, Chao LY, Dao DD, Strong LC, Pathak S, et al. (1987) Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 40: 413-420.
13. Yang JD, Roberts LR, (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
14. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750-4756.
15. Huang J, Zhang X, Zhang M, Zhu JD, Zhang YL, et al. (2007) Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 28: 1094-1103.
16. Kim KS, Lee YI, (1997) Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 119: 143-148.
17. Li X, Nong Z, Ekstrom C, Larsson E, Nordlinder H, et al. (1997) Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 57: 2048-2054.
18. Midorikawa Y, Yamamoto S, Ishikawa S, Kamimura N, Igarashi H, et al. (2006) Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 25: 5581-5590.
19. Poirier K, Chalas C, Tissier F, Couvert P, Mallet V, et al. (2003) Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma. J Pathol 201: 473-479.
20. Scelfo RA, Schwienbacher C, Veronese A, Gramantieri L, Bolondi L, et al. (2002) Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene 21: 2564-2572.
21. Schwienbacher C, Gramantieri L, Scelfo R, Veronese A, Calin GA, et al. (2000) Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A 97: 5445-5449.
22. Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, et al. (1996) Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 12: 1589-1592.
23. Uchida K, Kondo M, Takeda S, Osada H, Takahashi T, et al. (1997) Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 18: 193-198.
24. Wu J, Qin Y, Li B, He WZ, Sun ZL, (2008) Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics 91: 443-450.
25. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, et al. (2005) Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 92: 1574-1580.
26. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A, (2005) Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 90: 2179-2186.
27. Zhou Y, Zhang X, Klibanski A, (2012) MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 48: R45-53.
28. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-180.
29. Kagami M, O'Sullivan MJ, Green AJ, Watabe Y, Arisaka O, et al. (2010) The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet 6: e1000992.
30. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, et al. (2008) Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 40: 237-242.
31. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, et al. (2000) Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 5: 211-220.
32. Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, et al. (2010) Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn 12: 177-183.
33. Stoot JH, Coelen RJ, De Jong MC, Dejong CH, (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12: 509-522.
34. Nahm CB, Ng K, Lockie P, Samra JS, Hugh TJ, (2011) Focal nodular hyperplasia-a review of myths and truths. J Gastrointest Surg 15: 2275-2283.
35. Wilkins RJ, (1988) Genomic imprinting and carcinogenesis. Lancet 1: 329-331.
36. Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, et al. (1998) Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 17: 1739-1741.
37. Tessema M, Langer F, Bock O, Seltsam A, Metzig K, et al. (2005) Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol 26: 499-507.
38. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, et al. (1998) Activation of p73 silent allele in lung cancer. Cancer Res 58: 2347-2349.
39. Park YN, (2011) Update on precursor and early lesions of hepatocellular carcinomas. Archives of pathology & laboratory medicine 135: 704-715.
40. Trankenschuh W, Puls F, Christgen M, Albat C, Heim A, et al. (2010) Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS One 5: e13688.
41. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, et al. (2008) Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 68: 6779-6788.
42. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, et al. (2010) A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70: 10202-10212.
43. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, et al. (2009) CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 34: 148-153.
44. Luk JM, Burchard J, Zhang C, Liu AM, Wong KF, et al. (2011) DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 286: 30706-30713.
45. Khoury H, Suarez-Saiz F, Wu S, Minden MD, (2010) An upstream insulator regulates DLK1 imprinting in AML. Blood 115: 2260-2263.
46. Lehmann U, Hasemeier B, Lilischkis R, Kreipe H, (2001) Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens. Lab Invest 81: 635-638.
47. Potapova A, Albat C, Hasemeier B, Haeussler K, Lamprecht S, et al. (2011) Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution. BMC biotechnology 11: 6.
48. Royo JL, Galan JJ, (2009) Pyrosequencing for SNP genotyping. Methods Mol Biol 578: 123-133.